Alnylam Pharmaceuticals | Créanciers Commerciaux



Trade Creditors Changement Date
Acadia Pharmaceuticals USD 20.1M 2M 2025-06
Agios Pharmaceuticals USD 17.53M 3.81M 2025-06
Alnylam Pharmaceuticals USD 102.39M 4.99M 2025-06
Amgen USD 18.03B 15.63B 2025-06
Arrowhead Research USD 33.05M 23.07M 2025-06
BioMarin Pharmaceutical 684.25M 390.5M 2025-06
Incyte USD 1.41B 1.21B 2025-06
Ionis Pharmaceuticals USD 22.8M 5.34M 2025-06
Moderna USD 175M 51M 2025-06
Neurocrine Biosciences 104.6M 5.4M 2025-06
Novartis USD 4.57B 485M 2024-12
PTC Therapeutics USD 206.31M 191.16M 2025-06
Regeneron Pharmaceuticals USD 723.9M 18.4M 2025-06
Sanofi 7.55B 118M 2024-12
Sarepta Therapeutics USD 136.7M 19.4M 2025-06
Takeda JPY 421.31B 54.23B 2025-06
Tectonic Therapeutic USD 976K 1.66M 2024-12
Ultragenyx Pharmaceutical USD 34.24M 13.21M 2025-06
Vertex Pharmaceuticals USD 3.71B 3.27B 2025-06
Xencor USD 18.53M 2.34M 2025-06


Alnylam Pharmaceuticals Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.